Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

BACKGROUND Oral mucositis (OM) is a significant toxicity of induction chemotherapy for locally advanced head and neck cancer (LAHNC). The safety and tolerability of AG013, an oral rinse containing recombinant Lactococcus lactis secreting mucosal protectant human trefoil factor 1 (hTFF1), was evaluat...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Vol. 119; no. 24; pp. 4268 - 4276
Main Authors: Limaye, Sewanti Atul, Haddad, Robert I., Cilli, Fiona, Sonis, Stephen T., Colevas, A. Dimitrios, Brennan, Michael T., Hu, Kenneth S., Murphy, Barbara A.
Format: Journal Article
Language:English
Published: Hoboken, NJ Wiley-Blackwell 15.12.2013
Subjects:
ISSN:0008-543X, 1097-0142, 1097-0142
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first